Advantages of metformin for a diversity of diseases
Abstract
Because of its affordability and safety, metformin is a commonly used biguanide medication. Because of its exceptional capacity to lower plasma glucose levels, it has been used for more than 60 years to treat type 2 diabetes in its early stages. As metformin was used for more and more conditions, including aging and numerous diseases, its advantages came to light. Cancers (such as breast, endometrial, bone, colorectal, and melanoma), obesity, liver, cardiovascular, and renal illnesses are some of these conditions. Diverse signaling pathways allow metformin to exert its effects in different ways. The underlying mechanics of these many advantages still need to be clarified. This review's objectives are to briefly summarise the advantages of metformin and talk about potential underlying mechanisms.
Read the paper
Related studies
- The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
- Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
- Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model
- Modulating Sirtuin Biology and Nicotinamide Adenine Diphosphate Metabolism in Cardiovascular Disease—From Bench to Bedside
- Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
- Early Treatment with Empagliflozin and GABA Improves β-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.